Covaxin shows robust immune response, no serious adverse events: Bharat Biotech

The #Covid19Vaccine by Hyderabad-based Bharat Biotech, #Covaxin, has been found to have a robust immune response, without any severe adverse events, among the people who were immunized with it as part of the Phase-I clinical trials. Also, the vaccine is well-tolerated in all dose groups and it can be stored between 2-8 degree Celsius temperature, which is compatible with all Indian immunization programs.

published on : 17th December 2020